These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21488656)

  • 1. Assessment of methods to define the applicability domain of structural alert models.
    Ellison CM; Sherhod R; Cronin MT; Enoch SJ; Madden JC; Judson PN
    J Chem Inf Model; 2011 May; 51(5):975-85. PubMed ID: 21488656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing predictive performance of CASE Ultra expert system models using the applicability domains of individual toxicity alerts.
    Chakravarti SK; Saiakhov RD; Klopman G
    J Chem Inf Model; 2012 Oct; 52(10):2609-18. PubMed ID: 22947043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merging applicability domains for in silico assessment of chemical mutagenicity.
    Liu R; Wallqvist A
    J Chem Inf Model; 2014 Mar; 54(3):793-800. PubMed ID: 24494696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and validation of expert (Q)SAR systems.
    Hulzebos E; Sijm D; Traas T; Posthumus R; Maslankiewicz L
    SAR QSAR Environ Res; 2005 Aug; 16(4):385-401. PubMed ID: 16234178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations.
    Hillebrecht A; Muster W; Brigo A; Kansy M; Weiser T; Singer T
    Chem Res Toxicol; 2011 Jun; 24(6):843-54. PubMed ID: 21534561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in silico models for prediction of mutagenicity.
    Bakhtyari NG; Raitano G; Benfenati E; Martin T; Young D
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(1):45-66. PubMed ID: 23534394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
    Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the computer programs DEREK and TOPKAT to predict bacterial mutagenicity. Deductive Estimate of Risk from Existing Knowledge. Toxicity Prediction by Komputer Assisted Technology.
    Cariello NF; Wilson JD; Britt BH; Wedd DJ; Burlinson B; Gombar V
    Mutagenesis; 2002 Jul; 17(4):321-9. PubMed ID: 12110629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated decision support for assessing chemical liabilities.
    Spjuth O; Eklund M; Ahlberg Helgee E; Boyer S; Carlsson L
    J Chem Inf Model; 2011 Aug; 51(8):1840-7. PubMed ID: 21774475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three new consensus QSAR models for the prediction of Ames genotoxicity.
    Votano JR; Parham M; Hall LH; Kier LB; Oloff S; Tropsha A; Xie Q; Tong W
    Mutagenesis; 2004 Sep; 19(5):365-77. PubMed ID: 15388809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of new structural alerts suitable for chemical category formation for assigning covalent and non-covalent mechanisms relevant to DNA binding.
    Enoch SJ; Cronin MT
    Mutat Res; 2012 Mar; 743(1-2):10-9. PubMed ID: 22260876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the structural requirements for mutagencitiy, by incorporating molecular flexibility and metabolic activation of chemicals. II. General Ames mutagenicity model.
    Serafimova R; Todorov M; Pavlov T; Kotov S; Jacob E; Aptula A; Mekenyan O
    Chem Res Toxicol; 2007 Apr; 20(4):662-76. PubMed ID: 17381132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of the applicability domains of knowledge-based predictive toxicology expert systems by using a structural fragment-based approach.
    Ellison CM; Enoch SJ; Cronin MT; Madden JC; Judson P
    Altern Lab Anim; 2009 Nov; 37(5):533-45. PubMed ID: 20017582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated approach to assess the domain of applicability of some commercial (Q)SAR models.
    Kulkarni SA; Zhu J
    SAR QSAR Environ Res; 2008; 19(1-2):39-54. PubMed ID: 18311633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamates and ICH M7 classification: Making use of expert knowledge.
    Hemingway R; Fowkes A; Williams RV
    Regul Toxicol Pharmacol; 2017 Jun; 86():392-401. PubMed ID: 28385577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hierarchical Rules for Read-Across and In Silico Models of Mutagenicity.
    Benfenati E; Manganelli S; Giordano S; Raitano G; Manganaro A
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2015; 33(4):385-403. PubMed ID: 26403277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.
    Araya S; Lovsin-Barle E; Glowienke S
    Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Toxtree and SciQSAR in silico predictive software using a publicly available benchmark mutagenicity database and their applicability for the qualification of impurities in pharmaceuticals.
    Contrera JF
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):285-93. PubMed ID: 23969001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational derivation of structural alerts from large toxicology data sets.
    Ahlberg E; Carlsson L; Boyer S
    J Chem Inf Model; 2014 Oct; 54(10):2945-52. PubMed ID: 25275755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico prediction of chemical Ames mutagenicity.
    Xu C; Cheng F; Chen L; Du Z; Li W; Liu G; Lee PW; Tang Y
    J Chem Inf Model; 2012 Nov; 52(11):2840-7. PubMed ID: 23030379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.